Maglangit, Alma May G.
HRN: 21-89-56 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
CEFUROXIME 500MG (TAB)
09/24/2025
10/01/2025
ORAL
500mg
BID
S/P NSD With Repair
Checking Initial Appropriateness
09/24/2025
CEFUROXIME 500MG (TAB)
09/24/2025
10/01/2025
ORAL
500mg
BID
S/P NSD With Repair
Checking Initial Appropriateness